Neurology
AlphaGenome Makes Variant Interpretation Political
Google DeepMind’s AlphaGenome can predict how DNA sequence changes affect gene regulation, giving precision medicine a powerful new research tool, but not yet a shortcut to clinical interpretation.
AI Diagnosis Has Entered the Access Debate
AI in Cardiology Moves From Promise to Policy Pressure
Cyberbullying Becomes a Youth Mental Health Policy Target
Alzheimer’s Agitation Gets a New Drug, But Care Pathways Still Lag
Rare Epilepsy Moves Toward Treating the Cause
Huntington Gene Therapy Hits the Evidence Wall
Rare Disease Policy Moves Into the Individualised Therapy Era
Digital Mental Health Still Has an Evidence Problem
Alzheimer’s Access Now Starts With Genotyping and MRI Capacity
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.